Clinical trial Recruiting at 1 site Interventional Ages 11 to 18 Women only

Personalized neurostimulation for children with gastrointestinal disorders

Official title: Autonomic Reactivity to Restore a Dysregulated Brain-Gut Axis Via Targeted Therapy

Run by Medical College of Wisconsin · NCT06863207 · Data updated 2026-11-12

This study is testing a new treatment that combines personalized nerve stimulation and hypnotherapy to see if it can help children with stomach problems feel better.

Quick facts

Study typeInterventional
Ages11 Years to 18 Years
SexWomen only
Enrollment120 (estimated)
SponsorMedical College of Wisconsin
Academic / other
Locations1 site (Milwaukee, Wisconsin)
StatusRecruiting
StartedJanuary 24, 2025
Main results expectedDecember 2028
Study endsJune 2029
Registry record updatedFebruary 13, 2026
Trial IDNCT06863207 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking children aged 11 to 18 who meet diagnostic criteria for cyclic vomiting syndrome or functional dyspepsia and exhibit symptoms of autonomic dysfunction.

Probably not a fit

Patients with organic diseases explaining their symptoms, severe mental health disorders, or those requiring parenteral nutrition are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of personalized percutaneous electrical nerve field stimulation (PENFS) combined with hypnotherapy to treat children suffering from functional gastrointestinal disorders (FGIDs) and autonomic nervous system dysregulation. The researchers aim to assess real-time autonomic nervous system (ANS) regulation using a novel software while personalizing stimulation parameters based on individual sensory thresholds. The study will evaluate the feasibility and efficacy of these interventions over a six-week period, focusing on improvements in symptoms and autonomic function. By understanding the underlying mechanisms of gut-brain interaction, the study seeks to provide targeted treatment options for affected children.

Why it matters

Potential benefit: If successful, this approach could lead to more effective, personalized treatments for children with debilitating gastrointestinal disorders and associated autonomic dysfunction.

How similar studies have gone: While the approach of combining neurostimulation with hypnotherapy is innovative, similar studies have shown promise in treating related conditions, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 11 to 18 years of age
* English speaking
* meeting Rome IV diagnostic criteria for cyclic vomiting syndrome or functional dyspepsia and willingness to participate and consent/assent to the study
* All subjects will have a constellation of chronic symptoms indicative of autonomic dysfunction for minimum 3 months: postural dizziness/lightheadedness, syncope, palpitations, fatigue, sleep disturbance, thermoregulatory abnormalities and cognitive impairment with upright position +/- abnormal autonomic testing if performed per standard of care as per American Autonomic Society consensus criteria.

Exclusion Criteria:

* Presence of organic disease that may explain symptoms
* Requirement for parenteral nutrition
* Developmental delays precluding accurate symptom report
* Severe dermatological condition or active infection of external or middle ear
* Implanted electrical device
* Severe mental health disorder not controlled by therapy (schizophrenia, bipolar disease, severe depression, post-traumatic distress disorder) and/or psychotic features which could influence symptom report or ANS measurements and result in adverse reactions to hypnosis therapy

Where it's running

  • Medical College of Wisconsin
    Milwaukee, Wisconsin, United States
    Recruiting

Study contacts

  • Principal investigator: Katja Karrento, MD — Medical College of Wisconsin
  • Study coordinator: Elaina Schueler, BS
  • Email: eschueler@mcw.edu
  • Phone: 4142663695

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.